This study marked the first direct examination of hair follicle health in relation to creatine supplementation, offering compelling evidence that refutes the idea that creatine causes hair loss
Early animal data suggested greater GH selectivity and less ACTH/cortisol release than older GHRPs, but human safety and endocrine selectivity are not fully established
Evidence gaps No published human randomized trial has evaluated injectable GHK-Cu for cosmetic, hair, or wound endpoints
Conclusions A large body of preclinical data has indicated that inhibition of the insulin/IGF-1 system has a therapeutic benefit for cancer-bearing animals
Hospira products are recognized as being reliable, clinically-grade safe, and compatible with healthcare procedures and are critical in drug dilution, reconstitution, and fluid management
Within experimental and pharmacological research, GLP-1 pathways are widely investigated for their influence on glucose metabolism, energy balance, and appetite control mechanisms